APA način citiranja (7. izdanje)

(16676029), A. C. F., (16676032), D. K. M., (15084264), S. P. A., (16676035), A. E. S., (16676038), W. B., (16676041), L. J., . . . (16676080), S. D. R. (2025). Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.

Čikaški stil citiranja (17. izdanje)

(16676029), Alyssa C. Flint, et al. Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma. 2025.

MLA način citiranja (9. izdanje)

(16676029), Alyssa C. Flint, et al. Table S2 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma. 2025.